Pharmacological inhibition of PERK with GSK2606414 markedly reduces micro-vessel density and suppresses tumor growth, whereas pharmacological activation with CCT020312 has the opposite effect, amplifying EndoMT, angiogenesis, and tumor progression [63]. Here, EIF2AK3 is linked to neoplasm.